Shingrix (GlaxoSmithKline Biologicals SA)
Welcome to the PulseAid listing for the Shingrix drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline Biologicals SA |
NON-PROPRIETARY NAME: | gE Recombinant Varicella Zoster Virus (VZV) glycoprotein E |
SUBSTANCE NAME: | |
TYPE: | VACCINE |
PHARMA CLASS: | |
ROUTE: | |
DOSAGE FORM: | KIT |
MARKETING CATEGORY NAME: | BLA |
START MARKETING DATE: | 2017-10-20 |
END MARKETING DATE: | 0000-00-00 |
Shingrix VACCINE Details:
Item Description | Shingrix from GlaxoSmithKline Biologicals SA |
LABELER NAME: | GlaxoSmithKline Biologicals SA |
DEA SCHEDULE: | |
ACTIVE STRENGTH: | () |
START MARKETING DATE: | 2017-10-20 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 58160-819_0280849d-5c78-4a9d-8941-4eab429f6bd8 |
PRODUCT NDC: | 58160-819 |
APPLICATION NUMBER: | BLA125614 |